ArticleESC heart failure2024
Apixaban in bridge to transplant and destination LVAD - rationale and study design: the ApixiVAD trial.
Bruno Schnegg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it